Amgen (AMGN) PT Lowered to $234 at Barclays
Tweet
Share
E-mailGet Alerts AMGN Hot Sheet
Price: $439.33 +1.29%
Rating Summary:
20 Buy, 18 Hold, 5 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
20 Buy, 18 Hold, 5 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Barclays analyst Carter Gould lowered the price target on Amgen (NASDAQ: AMGN) to $234.00 (from $236.00) while maintaining a Equalweight rating.
You May Also Be Interested In
- FTC files amicus brief challenging Amgen's Enbrel patent acquisition
- Amgen (AMGN) PT Raised to $460 at Argus
- Intchains Group Ltd (ICG) PT Lowered to $2 at Benchmark Following 1H Results
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
